Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
28.59
+2.12 (8.01%)
At close: Aug 22, 2025, 4:00 PM
28.60
+0.01 (0.03%)
After-hours: Aug 22, 2025, 7:14 PM EDT
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $1.73 billion as of August 22, 2025. Its market cap has decreased by -33.88% in one year.
Market Cap
1.73B
Enterprise Value
1.57B
1-Year Change
-33.88%
Ranking
Category
Stock Price
$28.59
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $1.73B, an increase of 363.23%. That is a compound annual growth rate of 25.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1.73B | -37.44% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | 6.82B | 881.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.16B |
| Johnson & Johnson | 431.91B |
| AbbVie | 370.48B |
| UnitedHealth Group | 277.54B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 231.24B |